Syndax Pharmaceuticals (Nasdaq: SNDX) and Royalty Pharma plc (Nasdaq: RPRX) today announced that Syndax has entered into a $350 million synthetic royalty funding agreement with Royalty Pharma based on ...
In June 1994 the company entered into a management agreement with Lufthansa to manage their entire Airline operations. The company suspended their Airline operations in the year 1996 after dissensions ...